Bacsur Péter and Matuz Mária and Resál Tamás and Miheller Pál and Szamosi Tamás and Schäfer Eszter and Sarlós Patrícia and Iliás Ákos and Szántó Kata Judit and Rutka Mariann and Bálint Anita and Milassin Ágnes and Fábián Anna and Bor Renáta and Szepes Zoltán and Molnár Tamás and Farkas Klaudia:
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 15 (January-December).
pp. 1-18.
ISSN 1756-283X
(2022)